GB0320477D0 - A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate - Google Patents

A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate

Info

Publication number
GB0320477D0
GB0320477D0 GBGB0320477.3A GB0320477A GB0320477D0 GB 0320477 D0 GB0320477 D0 GB 0320477D0 GB 0320477 A GB0320477 A GB 0320477A GB 0320477 D0 GB0320477 D0 GB 0320477D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulation
metered dose
dose inhaler
fluticasone propionate
inhaler containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0320477.3A
Other versions
GB2388843B (en
GB2388843A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9921396.9A external-priority patent/GB9921396D0/en
Priority claimed from GB0014451A external-priority patent/GB0014451D0/en
Priority claimed from GB0018654A external-priority patent/GB0018654D0/en
Priority to GB0328426A priority Critical patent/GB2392164B/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0328773A priority patent/GB2392915B/en
Priority claimed from GB0022222A external-priority patent/GB2354007B/en
Publication of GB0320477D0 publication Critical patent/GB0320477D0/en
Publication of GB2388843A publication Critical patent/GB2388843A/en
Publication of GB2388843B publication Critical patent/GB2388843B/en
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
GB0320477A 1999-09-11 2000-09-11 A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate Expired - Fee Related GB2388843B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0328773A GB2392915B (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate
GB0328426A GB2392164B (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9921396.9A GB9921396D0 (en) 1999-09-11 1999-09-11 Pharmaceutical formulation
GB0014451A GB0014451D0 (en) 2000-06-13 2000-06-13 Pharmaceutical formulation
GB0018654A GB0018654D0 (en) 2000-07-28 2000-07-28 Pharmaceutical formulation
GB0022222A GB2354007B (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate

Publications (3)

Publication Number Publication Date
GB0320477D0 true GB0320477D0 (en) 2003-10-01
GB2388843A GB2388843A (en) 2003-11-26
GB2388843B GB2388843B (en) 2004-03-03

Family

ID=27625434

Family Applications (2)

Application Number Title Priority Date Filing Date
GB0320477A Expired - Fee Related GB2388843B (en) 1999-09-11 2000-09-11 A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate
GB0312326A Expired - Fee Related GB2385596B (en) 1999-09-11 2000-09-11 Container for pharmaceutical formulation of fluticasone propionate

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0312326A Expired - Fee Related GB2385596B (en) 1999-09-11 2000-09-11 Container for pharmaceutical formulation of fluticasone propionate

Country Status (1)

Country Link
GB (2) GB2388843B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2079210T3 (en) * 1991-12-12 1996-01-01 Glaxo Group Ltd PHARMACEUTICAL FORMULATION OF AEROSOL.
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
CN1113675C (en) * 1995-04-14 2003-07-09 葛兰素惠尔康公司 Metered dose inhaler for fluticasone propionate
IES80485B2 (en) * 1996-12-04 1998-08-12 Bioglan Ireland R & D Ltd Pharmaceutical compositions and devices for their administration
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
GB2388843B (en) 2004-03-03
GB2388843A (en) 2003-11-26
GB2385596B (en) 2004-03-03
GB2385596A (en) 2003-08-27
GB0312326D0 (en) 2003-07-02

Similar Documents

Publication Publication Date Title
HUS1800032I1 (en) Stable pharmaceutical solution formulations for pressurised metered dose inhalers
NZ305787A (en) Metered dose inhaler for fluticasone propionate
AP9701112A0 (en) Metered dose inhaler for fluticasone propionate
HUP0003917A3 (en) Dosage form for aerosol administration of water-sensitive medicaments
PL345399A1 (en) Pressurized metered dose inhalers and pharmaceutical aerosol formulations
NO974737D0 (en) Metered dose inhaler for albuterol
EP1066072A4 (en) Metered dose inhaler agitator
NO974736D0 (en) Metered dose inhaler for salmeterol
EP1250127A4 (en) A method of administering a medicinal aerosol formulation
EE04451B1 (en) Powder inhaler capsule for pharmaceutical formulations
IL154403A0 (en) Pharmaceutical formulation of salmeterol and fluticasone propionate
GB2388843B (en) A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate
HUP9904320A3 (en) Pharmaceutical compositions of weak acid drugs for colonic delivery
GB2392164B (en) Pharmaceutical formulation of fluticasone propionate
SI0820322T1 (en) Metered dose inhaler for fluticasone propionate
SI1166811T1 (en) Metered dose inhaler for fluticasone propionate
AU2003202441A1 (en) Metered dose inhaler for fluticasone propionate
AU2002301285A1 (en) Metered dose inhaler for fluticasone propionate
DE29903161U1 (en) Inhaler for metered dose inhalers
HU0800754D0 (en) Ressurised metered dose inhalers

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20120911